Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease is a research paper published in Science Translational Medicine (2023). On theSindex it has a DataRank of 0.875. It has been cited 340 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.875
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIA NIH HHS
Grant: P01 AG003991
NIH HHS
Grant: S10 OD025214
NIA NIH HHS
Grant: R01 AG057680
NIA NIH HHS
Grant: P01 AG026276
NIDDK NIH HHS
Grant: P30 DK052574
FWCI
31.47
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response
Additional file 1 of Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response